Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

34.29
Delayed Data
As of Jul 28
 +2.75 / +8.72%
Today’s Change
26.97
Today|||52-Week Range
34.88
+1.00%
Year-to-Date
AstraZeneca (AZN) Stock Up After Q2 Earnings, Revenue Beat
Jul 28 / TheStreet.com - Paid Partner Content
In Case You Missed It, 5 New Lung Cancer Drugs Have Been Approved Since October
Jul 23 / MotleyFool.com - Paid Partner Content
AstraZeneca (AZN) Leading In Pre-Market Activity
Jul 28 / TheStreet.com - Paid Partner Content
European Stock Markets Mixed After Signs of Brexit Damage
Jul 22 / TheStreet.com - Paid Partner Content
AstraZeneca Earnings, Sales Edge Above Forecasts
Jul 28 / TheStreet.com - Paid Partner Content
Sorry, You Can't Buy This Hot Biotech -- At Least Not Directly
Jul 21 / MotleyFool.com - Paid Partner Content
3 Stocks Boosting The Health Care Sector Higher
Jul 27 / TheStreet.com - Paid Partner Content
Why Shares of Relypsa Are Soaring Today
Jul 21 / MotleyFool.com - Paid Partner Content
Analysts' Actions -- GE, Nordstrom, Rockwell Collins, Sprint and More
Jul 26 / TheStreet.com - Paid Partner Content
Valeant/Progenics Relistor Ok'd; FDA Panel Backs Brodalumab
Jul 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close31.54
Today’s open32.54
Day’s range32.51 - 34.35
Volume20,001,285
Average volume (3 months)4,985,877
Market cap$79.8B
Dividend yield4.08%
Data as of 4:03pm ET, 07/28/2016

Growth & Valuation

Earnings growth (last year)+128.05%
Earnings growth (this year)-6.91%
Earnings growth (next 5 years)+1.40%
Revenue growth (last year)-5.11%
P/E ratio29.8
Price/Sales3.48
Price/Book4.31

Competitors

 Today’s
change
Today’s
% change
CELGCelgene+3.15+2.91%
LLYEli Lilly and Co-0.47-0.56%
ABTAbbott Laboratories+0.78+1.79%
SHPGShire-3.01-1.55%
Data as of 4:01pm ET, 07/28/2016

Financials

Last reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.43
Annual revenue (last year)$24.7B
Annual profit (last year)$2.8B
Net profit margin11.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Pascal Soriot
Executive VP-Operations &
Information Technology
Pam P. Cheng
Corporate headquarters
London, Greater London

Forecasts

Partner Offers

Search for Jobs